Martin Biermann

University of Bergen

Papers

1

Total Citations

22

H-Index

1

About

Martin Biermann is a leading figure in the field of urologic oncology, with a focused expertise in improving risk stratification for prostate cancer through advanced imaging. His most influential work centers on the integration of multiparametric MRI (mpMRI) into established clinical tools. In his highly cited 2017 study, Biermann demonstrated how incorporating mpMRI features into the CAPRA and D’Amico risk models significantly enhances their preoperative predictive accuracy. Analyzing a cohort of 807 patients undergoing robot-assisted radical prostatectomy, his research provided a critical evidence base for personalizing treatment decisions and reducing both overtreatment and undertreatment. With 22 citations, this work has become a cornerstone for clinicians seeking to optimize surgical planning and patient counseling. Beyond this key contribution, Biermann’s research portfolio consistently bridges the gap between radiological innovation and surgical outcomes, making him a respected voice in the movement toward precision medicine in prostate cancer care. His work continues to shape how urologists and radiologists collaborate to improve prognostic accuracy for patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Optimising preoperative risk stratification tools for prostate cancer using mpMRI
22 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Bergen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago